The discontinuation of three-digit score reporting for the United States Medical Licensing Examination Step 1 has pushed ...
Boehringer Ingelheim today announced that The New England Journal of Medicine (NEJM) published results from the Phase 1b Beamion LUNG-1 trial of HERNEXEOS (zongertinib tablets) in ...